Peter Powchik Insider Trading for January 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Peter Powchik.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of Peter Powchik for January 2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 03 2014 | REGN | REGENERON PHARMACE ... | Powchik Peter | SVP Clinical Develo ... | Option Exercise | M | 30.63 | 48,000 | 1,470,240 | 4,736 | |
| Jan 03 2014 | REGN | REGENERON PHARMACE ... | Powchik Peter | SVP Clinical Develo ... | Sell | S | 277.50 | 100 | 27,750 | 25,447 | 25.5 K to 25.4 K (-0.39 %) |
| Jan 03 2014 | REGN | REGENERON PHARMACE ... | Powchik Peter | SVP Clinical Develo ... | Sell | S | 276.75 | 1,296 | 358,668 | 25,547 | 26.8 K to 25.5 K (-4.83 %) |
| Jan 03 2014 | REGN | REGENERON PHARMACE ... | Powchik Peter | SVP Clinical Develo ... | Sell | S | 276.04 | 6,893 | 1,902,744 | 26,843 | 33.7 K to 26.8 K (-20.43 %) |
| Jan 03 2014 | REGN | REGENERON PHARMACE ... | Powchik Peter | SVP Clinical Develo ... | Sell | S | 274.69 | 3,777 | 1,037,504 | 33,736 | 37.5 K to 33.7 K (-10.07 %) |
| Jan 03 2014 | REGN | REGENERON PHARMACE ... | Powchik Peter | SVP Clinical Develo ... | Sell | S | 273.77 | 5,602 | 1,533,660 | 37,513 | 43.1 K to 37.5 K (-12.99 %) |
| Jan 03 2014 | REGN | REGENERON PHARMACE ... | Powchik Peter | SVP Clinical Develo ... | Sell | S | 272.88 | 3,000 | 818,640 | 43,115 | 46.1 K to 43.1 K (-6.51 %) |
| Jan 03 2014 | REGN | REGENERON PHARMACE ... | Powchik Peter | SVP Clinical Develo ... | Payment of Exercise | F | 276.09 | 22,007 | 6,075,913 | 46,115 | 68.1 K to 46.1 K (-32.31 %) |
| Jan 03 2014 | REGN | REGENERON PHARMACE ... | Powchik Peter | SVP Clinical Develo ... | Payment of Exercise | F | 276.09 | 5,325 | 1,470,179 | 68,122 | 73.4 K to 68.1 K (-7.25 %) |
| Jan 03 2014 | REGN | REGENERON PHARMACE ... | Powchik Peter | SVP Clinical Develo ... | Buy | M | 30.63 | 48,000 | 1,470,240 | 73,447 | 25.4 K to 73.4 K (+188.63 %) |